PRRT2 and Alzheimer disease: According to the results, the expression of PKCɛ was downregulated following the injection of amyloid beta in the hippocampus, but no significant difference between the AD and sham groups were observed in platelet that may be due to the low concentration of PKCɛ or duration of exposure to amyloid beta in the rat brain.